Series B - 23andMe
Investment Firm
Overview
23andMe is a DNA testing technology company that enables its users to access their ancestry, genealogy, and inherited traits.
Announced Date
Jun 18, 2009
Funding Type
Series B
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
3
| Investor Name |
|---|
 Sergey Brin |
Round Details and Background
23andMe raised $13600000 on 2009-06-18 in Series B
23andMe is a DNA testing technology company that enables its users to access their ancestry, genealogy, and inherited traits.
Company Funding History
14
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jan 07, 2011 |  Series C - 23andMe | 2 | - | 9.0M |
| Nov 09, 2010 | Series C - 23andMe | 3 | - | 22.2M |
| Jun 18, 2009 | Series B - 23andMe | 3 | - | 13.6M |
| Oct 03, 2007 | Series A - 23andMe | 6 | - | 9.0M |
Recent Activity
There is no recent news or activity for this profile.